PHIOGEN Information

PHIOGEN is a preclinical-stage biotechnology company pioneering a next-generation phage platform to treat and prevent drug-resistant and recurrent bacterial infections. A spin-out from Baylor College of Medicine, PHIOGEN operates from its dedicated lab at Helix Park within the Texas Medical Center, the world’s largest medical complex. The company’s proprietary platform integrates advanced screening, human-relevant models, and evolutionary selection to develop dual-function bacteriophages that both eliminate bacterial pathogens and stimulate protective immunity. PHIOGEN is advancing a pipeline of targeted phage therapies designed to redefine infectious disease treatment where conventional antibiotics fail. To learn more please visit www.phiogen-pharma.com